Private Placement

The Association of Related Churches marks 25 years with 32 new launches, but its rapid growth model draws both praise for its impact and questions over its methods.

Enveric Biosciences raises $1.5M to advance its novel psychiatric drugs. Is this small cash infusion enough to propel its promising pipeline forward?

Eliyan secures $50M from Meta, AMD, and Arm to scale its chiplet interconnects, a key technology for overcoming AI's data transfer limitations.

A landmark FDA decision allows Life Biosciences to test its epigenetic reprogramming therapy, ER-100, offering new hope for restoring sight in the blind.

Online reputation firm Ealixir reveals massive operational growth and a new strategic vision to combat AI's impact on digital identity, but faces a complex market.

With promising brain scan data, a deep therapeutic pipeline, and a cash runway into 2027, Radiopharm Theranostics is gaining significant momentum.

With a $1.88M prize pool and 788 teams, WEEX's global AI hackathon is a high-stakes stress test for the next generation of automated finance.

Longkou City launches a new comic IP based on a 2,000-year-old legend, using a shared historical figure to foster cultural diplomacy and economic growth.

A landmark deal will see Hana Bank finance critical AI chip imports, aiming to reshape fintech and bolster South Korea's global technology standing.

FSC's program gains top national recognition from U.S. News, blending flexibility for working professionals with the prestige of elite AACSB accreditation.

For 13 families in California's toughest housing markets, a local credit union's grant program turned the impossible dream of homeownership into reality.

Pritzker Alternative Strategies hires Joseph Kusnan, signaling a strategic move to leverage deep family office expertise in competitive private equity markets.

Specialized firms are solving complex tax credit puzzles, enabling developers to bring affordable solar energy to more homes, including low-income areas.

New research provides the strongest human evidence that sleep actively clears toxic proteins linked to Alzheimer's, opening a new frontier for prevention.

With drug pipelines facing staggering failure rates, HKeyBio's new preclinical strategy aims to de-risk R&D and accelerate effective new treatments.

Asset management giant Bitwise is launching professionally managed DeFi vaults, aiming to bring institutional capital to the world of onchain stablecoin yield.

With new President and CTO appointments, Hermeus signals a major shift from R&D to full-scale production of its high-Mach aircraft for defense.

Nuvve's new partnership with Capture Energy for modular battery systems aims to accelerate its V2G and grid services expansion across the Nordics.

A major shift in defense contracting, fueled by a $1.5T private capital wave, demands field-ready tech. Companies that can deliver are poised to win.

Onity Group is raising $150 million via high-yield notes, a strategic but risky move to refinance debt and fund growth amid a complex financial backdrop.